Looking up a semaglutide website? Here's what the official sources actually say

Which official UK sites hold the most reliable semaglutide information?

When you search for a semaglutide website, you'll land on a wide range of pages, manufacturer sites, pharmacy services, news articles and forum threads. The most authoritative UK starting points are the NHS semaglutide medicines page, which explains how the medicine works, common side effects and what to tell your doctor, and NICE technology appraisal TA875, which sets out the clinical criteria the NHS uses when recommending semaglutide for weight management. Novo Nordisk's own Wegovy UK site carries the approved product information, but it is manufacturer content, useful for brand-specific facts, less so for comparing your options.

For general semaglutide background, the semaglutide overview on this site pulls together the UK-specific licensing, evidence and eligibility detail in one place. If you want to look specifically at how Wegovy is positioned as a branded product, the Wegovy treatment page goes deeper into the injection schedule and what to expect from the titration process.

One thing worth knowing: Ozempic is also semaglutide, but it holds a different UK licence, it is authorised for type 2 diabetes, not weight loss. The dose used in Ozempic and the dose used in Wegovy are not equivalent. Any semaglutide website that presents them as interchangeable, or implies you can use one for the other's purpose, is giving you inaccurate information.

What does the current semaglutide evidence actually show for weight loss?

If you've spent time on a semaglutide website recently, you've probably seen a wide range of figures quoted, some accurate, some cherry-picked. The clearest UK-relevant data comes from the STEP 1 phase 3 trial, published in the New England Journal of Medicine, which followed adults with obesity over 68 weeks using the 2.4mg weekly maintenance dose. Average weight reduction was around 15%. That's a population average across everyone in the trial, not a minimum or a maximum.

More recently, the MHRA approved a higher 7.2mg maintenance dose. The dedicated single-dose pen for that strength was cleared on 14 April 2026 for adults with a BMI of 30 or above. If you're exploring what the step up from the standard dose involves, our semaglutide 2 page covers the detail on that higher-strength option. Whether that higher dose is right for a specific person is a clinical decision, not something any website, official or otherwise, can settle for you.

In June 2026, the MHRA also approved the first oral semaglutide for weight management: Wegovy tablets, escalating from 1.5mg up to a 25mg daily maintenance dose. For more on how treatment typically begins, including what to expect during the earlier phase, the semaglutide 1 page walks through the starting-dose period in practical terms. That 17% figure is often quoted without the adherence caveat, it matters to read it with context.

If you're comparing prices, what should a legitimate semaglutide website show you?

This is where many readers arrive feeling quietly frustrated, they've seen prices ranging from suspiciously low to eye-wateringly high and can't tell what's real. That's understandable. Since Eli Lilly raised Mounjaro's UK list price in September 2025, media coverage of GLP-1 pricing has been intense, and the semaglutide picture has been pulled into that conversation too.

A legitimate private semaglutide website should show you a complete price: the consultation, the prescription, the medicine itself and delivery. If a headline price excludes any of those, the real cost is higher than advertised. The MHRA has warned repeatedly about fake weight-loss pens sold through social media and unverified online sellers, some containing insulin rather than the labelled medicine. A price that looks far below the current market range is a reason to verify the pharmacy's registration, not a reason to celebrate.

You can check any pharmacy's GPhC registration at pharmacyregulation.org, that link takes you directly to our own GPhC entry (registration 9012878) so you can see exactly what a verified listing looks like. For a broader look at what private weight-loss treatment costs in practice, the Wegovy pricing page explains the factors that move the number, without hiding the full picture.

At nume, we don't run discount codes or promotions for prescription medicines. One transparent price covers the consultation, prescription, and free next-working-day tracked delivery. That's a deliberate choice, not an oversight. If price is a concern, the treatment options overview is a sensible starting point for understanding what's available.

How does a GPhC-registered online pharmacy differ from just reading a semaglutide website?

Reading about semaglutide online is a perfectly reasonable first step, it's how most people start. But there's a practical gap between information and access. A semaglutide website, however well-written, cannot assess your medical history, check your current medicines for interactions, review your blood pressure or verify your weight. A prescriber can.

At a GPhC-registered pharmacy like ours, the process starts with a clinical consultation (free to complete) which a named prescriber reads and assesses the same day. Identity and weight are verified before anything is dispatched. For anyone transferring from another provider or requesting a dose change, evidence is reviewed before the prescription is written. Our clinical team page gives you a clear picture of who is doing that reviewing.

If questions come up after you start treatment, our prescribers are reachable seven days a week. Side effects questions, missed-dose uncertainty, whether a new symptom needs attention, those conversations happen with a person, not a chatbot. The FAQs page covers the questions we hear most often, and the contact page is there for anything more specific. For anyone who wants to understand semaglutide at the detail level before deciding, the Wegovy official website overview is a useful companion read.